ResearcherNantong UniversityNo recent work listed

Jieying Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0576-1891; OpenAlex author ID A5048299924. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2017: 2 papers

Papers 2

Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation. Co-author DOI 10.1016/j.jconrel.2016.11.024 ↗
Effects of Rab27A and Rab27B on Invasion, Proliferation, Apoptosis, and Chemoresistance in Human Pancreatic Cancer Cells. Co-author DOI 10.1097/mpa.0000000000000910 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jianfei Huang · 2 shared papers, 2017 · strength 0.16
- Paper Effects of Rab27A and Rab27B on Invasion, Proliferation, Apoptosis, and Chemoresistance in Human Pancreatic Cancer Cell… DOI 10.1097/mpa.0000000000000910 ↗
- Paper Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation. DOI 10.1016/j.jconrel.2016.11.024 ↗
Zhiwei Wang · 1 shared paper, 2017 · strength 0.07
- Paper Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation. DOI 10.1016/j.jconrel.2016.11.024 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.